Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Verve Therapeutics, Inc. (VERV)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 89,140,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Verve Therapeutics is a genetic medicines company developing an approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. Co.'s primary product candidate, VERVE-101, is designed to turn off the PCSK9 gene in the liver. PCSK9 is a validated target that plays a critical role in controlling blood low-density lipoprotein cholesterol through its regulation of the low-density lipoprotein receptor. Co.'s second program is designed to turn off the ANGPTL3 gene in the liver. ANGPTL3 is a main regulator of cholesterol and triglyceride metabolism.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 1,876,000
Total Buy Value $0 $0 $0 $18,475,760
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 2
Total Shares Sold 24,054 24,054 24,609 26,677
Total Sell Value $99,824 $99,824 $102,954 $121,772
Total People Sold 6 6 6 6
Total Sell Transactions 6 6 7 9
End Date 2025-03-16 2024-12-13 2024-06-14 2023-06-15

   
Records found: 117
  Page 1 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Nickerson Joan Chief Administrative Officer   •       –      –    2025-04-02 4 S $4.15 $11,525 D/D (2,777) 17,420     -
   Politi Jason Chief Technical Ops. Off.   •       –      –    2025-04-02 4 S $4.15 $13,425 D/D (3,235) 14,226     -
   Lister Troy Chief Scientific Officer   •       –      –    2025-04-02 4 S $4.15 $9,084 D/D (2,189) 6,952     -
   Ashe Andrew D. See Remarks   •       –      –    2025-04-02 4 S $4.15 $11,126 D/D (2,681) 348,828     -
   Kathiresan Sekar Chief Executive Officer   •       •      –    2025-04-02 4 S $4.15 $40,761 D/D (9,822) 346,686     -
   Dorval Allison Chief Financial Officer   •       –      –    2025-04-02 4 S $4.15 $13,903 D/D (3,350) 13,280     -
   Nickerson Joan Chief Administrative Officer   •       –      –    2025-04-01 4 OE $0.00 $0 D/D 9,315 20,197     -
   Politi Jason Chief Technical Ops. Off.   •       –      –    2025-04-01 4 OE $0.00 $0 D/D 8,815 17,461     -
   Lister Troy Chief Scientific Officer   •       –      –    2025-04-01 4 OE $0.00 $0 D/D 7,340 9,141     -
   Ashe Andrew D. See Remarks   •       –      –    2025-04-01 4 OE $0.00 $0 D/D 9,000 351,509     -
   Kathiresan Sekar Chief Executive Officer   •       •      –    2025-04-01 4 OE $0.00 $0 D/D 33,000 356,508     -
   Dorval Allison Chief Financial Officer   •       –      –    2025-04-01 4 OE $0.00 $0 D/D 11,250 16,630     -
   Kathiresan Sekar Chief Executive Officer   •       •      –    2024-12-04 4 GA $0.00 $0 I/I 30,000 110,997     -
   Kathiresan Sekar Chief Executive Officer   •       •      –    2024-12-04 4 GD $0.00 $0 D/D 30,000 323,508     -
   Dorval Allison Chief Financial Officer   •       –      –    2024-12-02 4 S $5.64 $3,130 D/D (555) 5,380     -
   Dorval Allison Chief Financial Officer   •       –      –    2024-11-29 4 OE $0.00 $0 D/D 1,875 5,935     -
   Kathiresan Sekar Chief Executive Officer   •       •      –    2024-06-28 4 OE $2.87 $86,100 D/D 30,000 351,128     -
   Ashe Andrew D. See Remarks   •       –      –    2024-05-14 4 B $6.26 $475,760 D/D 76,000 342,509 0.01     -
   Nickerson Joan Chief Administrative Officer   •       –      –    2024-04-02 4 S $8.24 $12,475 D/D (1,514) 8,659     -
   Nickerson Joan Chief Administrative Officer   •       –      –    2024-04-01 4 OE $0.00 $0 D/D 3,315 10,173     -
   Alphabet Inc.   –       –      –    2023-12-01 3 IO $0.00 $0 I/I 0 1,800,000     -
   Yeshwant Krishna   –       •       •   2023-12-01 4 B $10.00 $18,000,000 I/I 1,800,000 1,800,000 0.01     -
   Dorval Allison Chief Financial Officer   •       –      –    2023-11-29 4 S $11.45 $6,343 D/D (554) 4,060     -
   Dorval Allison Chief Financial Officer   •       –      –    2023-11-29 4 OE $0.00 $0 D/D 1,875 4,614     -
   Nickerson Joan Chief Administrative OfficerOf   •       –      –    2023-02-15 3 IO $0.00 $0 D/D 0 5,494     -

  117 Records found
  1  2  3  4  5   
  Page 1 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed